The University of Southampton
University of Southampton Institutional Repository

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology
Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal burden. The present guidelines summarise current literature, generating expert consensus recommendations for the treatment of ADHD in children and adults. These guidelines also provide a review of recent research in the fields of neuroimaging, neuropsychology and genetics of ADHD. Novel discoveries in these areas have informed physiological models for the disease. Since the publication of the previous British Association for Psychopharmacology guidelines in 2008, new drugs have been licensed and further compounds are being investigated. The publication of randomised controlled trials of psychological interventions has contributed to the range of treatment options for ADHD. As the disorder has been diagnosed more frequently there has been greater focus on comorbid conditions and how they impact treatment. Services have continued to develop for the treatment of ADHD in adults and care agreements have been introduced to facilitate access to treatment.
add, adhd, bap, attention deficit and hyperactivity disorder, hyperkinetic disorder
0269-8811
179-203
Bolea-Alamanac, B.
9c8e72ef-d8df-4390-8a51-42765a474a4e
Nutt, D. J.
c4ce618c-d871-4d6c-9941-499b06a8adca
Adamou, M.
fd5e05e2-54ed-4a14-9a49-3519a6435bf8
Asherson, P.
4ecfa0c9-ea9c-47b9-aae8-429822c6c7ee
Bazire, S.
f077e352-d220-47c9-8588-4b0ec891af0f
Coghill, D.
a4b982d1-4788-41aa-90c5-b4a7f7dffad7
Heal, D.
18c2b2c7-4f61-4afe-96c7-b9a22574bd09
Muller, U.
76ef970b-e7c4-40e6-b251-a99ddf4e98c7
Nash, J.
c4b885a7-7a49-4551-a0d2-de172d97cf1e
Santosh, P.
83759ca4-e254-4733-be8d-df022df6ce89
Sayal, K.
6fa65716-fc5a-442d-bf77-8b687b109a86
Sonuga-Barke, E.
bc80bf95-6cf9-4c76-a09d-eaaf0b717635
Young, S. J.
918b04eb-3429-436c-b85a-84e1af41600f
Bolea-Alamanac, B.
9c8e72ef-d8df-4390-8a51-42765a474a4e
Nutt, D. J.
c4ce618c-d871-4d6c-9941-499b06a8adca
Adamou, M.
fd5e05e2-54ed-4a14-9a49-3519a6435bf8
Asherson, P.
4ecfa0c9-ea9c-47b9-aae8-429822c6c7ee
Bazire, S.
f077e352-d220-47c9-8588-4b0ec891af0f
Coghill, D.
a4b982d1-4788-41aa-90c5-b4a7f7dffad7
Heal, D.
18c2b2c7-4f61-4afe-96c7-b9a22574bd09
Muller, U.
76ef970b-e7c4-40e6-b251-a99ddf4e98c7
Nash, J.
c4b885a7-7a49-4551-a0d2-de172d97cf1e
Santosh, P.
83759ca4-e254-4733-be8d-df022df6ce89
Sayal, K.
6fa65716-fc5a-442d-bf77-8b687b109a86
Sonuga-Barke, E.
bc80bf95-6cf9-4c76-a09d-eaaf0b717635
Young, S. J.
918b04eb-3429-436c-b85a-84e1af41600f

Bolea-Alamanac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Muller, U., Nash, J., Santosh, P., Sayal, K., Sonuga-Barke, E. and Young, S. J. (2014) Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 28 (3), 179-203. (doi:10.1177/0269881113519509). (PMID:24526134)

Record type: Article

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal burden. The present guidelines summarise current literature, generating expert consensus recommendations for the treatment of ADHD in children and adults. These guidelines also provide a review of recent research in the fields of neuroimaging, neuropsychology and genetics of ADHD. Novel discoveries in these areas have informed physiological models for the disease. Since the publication of the previous British Association for Psychopharmacology guidelines in 2008, new drugs have been licensed and further compounds are being investigated. The publication of randomised controlled trials of psychological interventions has contributed to the range of treatment options for ADHD. As the disorder has been diagnosed more frequently there has been greater focus on comorbid conditions and how they impact treatment. Services have continued to develop for the treatment of ADHD in adults and care agreements have been introduced to facilitate access to treatment.

Full text not available from this repository.

More information

e-pub ahead of print date: 12 February 2014
Published date: 3 March 2014
Keywords: add, adhd, bap, attention deficit and hyperactivity disorder, hyperkinetic disorder
Organisations: Clinical Neuroscience

Identifiers

Local EPrints ID: 375560
URI: https://eprints.soton.ac.uk/id/eprint/375560
ISSN: 0269-8811
PURE UUID: 82cc7769-a02c-48b7-afa0-012677062744

Catalogue record

Date deposited: 30 Mar 2015 13:22
Last modified: 15 Jul 2019 21:25

Export record

Altmetrics

Contributors

Author: B. Bolea-Alamanac
Author: D. J. Nutt
Author: M. Adamou
Author: P. Asherson
Author: S. Bazire
Author: D. Coghill
Author: D. Heal
Author: U. Muller
Author: J. Nash
Author: P. Santosh
Author: K. Sayal
Author: E. Sonuga-Barke
Author: S. J. Young

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×